Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Researchers from Japan have uncovered direct evidence showing how ketamine exerts its rapid antidepressant effects in ...

Advanced Cardiology and Electrophysiology in Lufkin is now the first clinic in East Texas to offer cardiac PET/CT scanning - ...

VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 - - Validating brain-targeted capsids in humans: expect ...

The Bon Secours Hospital in Co Limerick was officially opened on Monday. It is the first new acute hospital to open in Ireland in two decades. The €213 million project is one of the largest healthcare ...

By Tarun Sai Lomte Scientists directly compared two leading pTau217 blood tests and found that a brain-derived version may detect Alzheimer’s-related brain pathology more accurately while avoiding ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agentcombines thediagnostic performance of PYLARIFY® (piflufolastat F 18) ...

Researchers used a novel PET tracer to visualize how ketamine alters AMPA receptor distribution in the brains of patients ...

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

PET-CT is widely recommended in international clinical guidelines, including those of the European Association of Nuclear ...

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...